Clinical Trials Sponsored by NX PharmaGen

Total 88 results

NX Development Corp

Not yet recruiting

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Ovarian Cancer
NX Development Corp

Active, not recruiting

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma (MEN-301)

Meningioma

United States, Austria, Germany
Constantinos Hadjipanayis
National Cancer Institute (NCI); NX PharmaGen

Withdrawn

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Glioblastoma | Brain Cancer | Brain Tumors | Brain Tumor, Recurrent | Benign Neoplasms, Brain | Brain Neoplasms, Benign | Brain Neoplasms, Malignant | Brain Tumor, Primary | Intracranial Neoplasms | Neoplasms, Brain | Neoplasms, Intracranial | Primary Brain Neoplasms | Primary Malignant Brain Neoplasms | Primary Malignant... and other conditions

United States
Pharmanex

Completed

Functional Test for a Drink Powder Alone and Combined Use With a Cosmetic Apparatus

Skin Elasticity | Beauty Drink Powder | Cosmetic Apparatus on Skin | Skin Dryness | Skin Moisture | Skin Evenness | Skin Firmness

China
Pharmanex

Active, not recruiting

Inflammatory and Metabolic Responses to Long-term Dietary Supplementation With Anthocyanin-rich Blend

Anthocyanins

United States
Pharmanex

Completed

Intestinal Inflammatory and Metabolic Responses to a High Fat Meal and Plant Polyphenol Blend

Anthocyanins

United States
Pharmanex

Completed

Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight

Obesity | Overweight

United States
Pharmanex

Completed

Beauty Image Efficacy Study

Skin Aging

China
PharmaIN

Recruiting

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

Cirrhosis, Liver | Liver Fibrosis | Ascites Hepatic

United States
PharmaJet, Inc.

Completed

Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe

Influenza Prophylaxis

United States
Massachusetts General Hospital
NX Development Corp

Unknown

A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

Pituitary Adenoma
Pharmagest Interactive

Completed

Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure (eNephro)

Chronic Kidney Diseases

France
PharmAkea, Inc.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

Healthy

United Kingdom
Pharmathen S.A.

Completed

A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment

Schizophrenia

Jordan
PharmaJet, Inc.

Completed

Inactivated Influenza Via Jet Injection (IIJI)

Influenza, Human

United States
PharmaJet, Inc.

Completed

Jet Injection for Influenza (JIFI)

Influenza, Human

United States
Biotec Pharmacon ASA

Completed

Evaluation of Woulgan in Diabetic Foot Ulcer

Diabetic Foot Ulcers

United Kingdom, Sweden
CoMentis
Alpharmagen, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects

Schizophrenia

United States
Biotec Pharmacon ASA

Completed

Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

Head and Neck Cancer | Oral Mucositis

France
Biotec Pharmacon ASA

Completed

Effect of SBG in Patients With Breast Cancer

Breast Cancer

Norway
Biotec Pharmacon ASA

Completed

Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Norway
Biotec Pharmacon ASA

Terminated

Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

Burns

Norway
Fralex Therapeutics
PharmaNet

Terminated

Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

Chronic Musculoskeletal Pain
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I

Mucopolysaccharidosis I

Brazil
ArmaGen, Inc

Completed

Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181

Mucopolysaccharidosis I
CoMentis
Alpharmagen, Inc.

Suspended

Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia

Schizophrenia

United States
Biotec Pharmacon ASA

Completed

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

Diabetes | Diabetic Ulcer

Spain
Biotec Pharmacon ASA

Completed

Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

Chronic Diabetic Foot Ulcers

United Kingdom
Biotec Pharmacon ASA

Completed

The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients

Oral Mucositis

Germany, United Kingdom
Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I

Mucopolysaccharidosis I

United States
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Mucopolysaccharidosis II

United States, Germany, Philippines
ArmaGen, Inc

Completed

Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I

Mucopolysaccharidosis I

Brazil
Pharmanex
Clinical Research Australia

Recruiting

Nutritional Supplement's Effects on Cognition

Healthy | Cognition | Dietary Supplement

Australia
Pharmanex
Utah State University

Completed

Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds

Healthy

United States
Pharmanex
KGK Science Inc.

Completed

Polyphenol/Prebiotic Blend Effects on GI Health and Microbial Composition

GI Health | Microbial Composition

Canada
Bristol-Myers Squibb
PharmaNet

Completed

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting (REMAIN)

HIV

Germany, Spain, Portugal
Golden Biotechnology Corporation
PharmaNet

Completed

Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects (Hocena)

Non-small Cell Lung Cancer

Taiwan
Pharmanex
Nu Skin Enterprises

Completed

Effects of a Nutritional Supplement Combination on Body Weight Management

Safety/Effacy

United States
Pharmanex
Utah State University

Completed

A Prospective Study Investigating the Effects of a Novel Weight Management Program

Overweight

United States
Pharmanex
University of Utah

Completed

Brain Imaging Study

Brain Health

United States
Pharmanex
Aspen Clinical Research

Completed

Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women (Pharmanex)

Anti Aging

United States
Icahn School of Medicine at Mount Sinai
NX Development Corp

Recruiting

The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

Neoplasm | Skull Base Neoplasm

United States
Wishbone SA
EVAMED; Pharmalex; Advimago

Recruiting

Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Safety Issues | Bone Regeneration

Belgium
Shire
PharmaNet; Nextrials, Inc.

Withdrawn

An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)

Leukodystrophy, Globoid Cell
Dr. Reddy's Laboratories Limited
PharmaNet

Completed

A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

Type II Hyperlipidemia

Ukraine, Poland, Italy
PharmaNet
Celtic Pharma Development Services

Terminated

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Peritumoral Brain Edema | PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
Pharmanex
Sprim Advanced Life Sciences

Completed

Effects of a Vitality Dietary Supplement on Physical and Mental Function in Middle-aged Adults

Health-related Quality of Life

United States
PATH
University of Maryland, Baltimore; Pharmaron

Completed

Cholera Anti-Secretory Treatment Trial (CAST)

Cholera

United States
Fralex Therapeutics
PharmaNet; McDougall Scientific Limited

Terminated

Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population

Pain | Fibromyalgia

United States, Canada

3

Subscribe